SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Introgen Therapeutics, Inc. And Gendux Announce Agreement With European Medicines Agency To File For ADVEXIN Approval Under Exceptional Circumstance Rules